Womans face
GSK GlaxoSmithKline
Cervical cancer can take ten years to develop. You can get vaccinated in minutes.

References

  1. Ferlay J, Bray P, Pizani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. IARCPress, Lyon, 2004
  2. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 2003; 348: 518-27
  3. Moscicki A.B. et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998: 132: 277-84.
  4. McIntosh N, Human papillomavirus and cervical cancer. JHPIEGO Strategy Paper No. 8, May 2000.
  5. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265
  6. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31: 14-19.
  7. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
  8. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13.
  9. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102 (5A): 3-8.
  10. Winer R.L. et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157(3): 218-226.
  11. Action on smoking and health. Factsheet No. 4 smoking and cancer. www.ash.org.uk. Accessed September 2007
  12. NHS Cervical Screening Programme, England: 2004-2005 http//www.ic.nhs.uk/pubs/cervicscrnrng2005/sb0509.pdf/file. Accessed Aug 2007.
  13. Summary of product characteristics – Gardasil 2007
  14. Summary of product characteristics – Cervarix 2007.
  15. Peto J. et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004; 364 (9430): 249-56.
  16. Sasieni P. et al. Beneit of cervical screeing histories. Br J Cancer 2003; 89(1): 88-93.
  17. Cancer Research UK statistics – Incidence and mortality. Accessed 2006.


Arrow icon Back to top

CERVICAL CANCER. BE SMART. THINK PREVENTION.
Contact us - Tel: 0800 234 6642   Fax: 0800 111 222

© 2007 GlaxoSmithKline group of companies. All rights reserved.
GlaxoSmithKline UK Limited : Registered in England & Wales No 4310159
Registered office 980 Great West Road, Brentford, Middlesex TW8 9GS
This site is for UK residents only

Legal Statement Privacy Statement

CCD/WEB/07/32017/1 October 2007